BenolielJ.Q. (1986). Nursing practice and the quality of life, in McCorkleR. & HongladaromG. (eds.): Issues and topics in cancer nursing. Norwalk, Connecticut: Appleton-Century-Crofts.
2.
CoreyB.S. & CollinsJ.L. (1986). Implementation of an RIL-2/LAK cell clinical trial: A nursing perspective. Oncology Nursing Forum, 13(6), 31–36.
3.
FarrisJ.S. & MayerD. (1983, Fall). A guide to interferon for patients and nurses. Oncology Nursing Forum, 10(4), 65–68.
4.
GarveyE.C.MatutatR.J. & BoltonD. (1983). Care of the patient undergoing interferon therapy. Cancer Nursing, 303–306.
5.
GadonR.S. (1986). Advocacy and paternalism in cancer nursing, in McCorkleR. & HongladaromG. (eds.): Issues and topics in cancer nursing. Norwalk, Connecticut: Appleton-Century-Crofts.
6.
HardyM.E. (1978). Perspectives on knowledge and role theory, in HardyM.E. & ConwayM.E. (Eds.): Role theory: Perspectives for health professionals. New York: Appleton-Century-Crofts.
7.
JeffsC. & LaszloJ. (1983). A coordinating role for the nurse clinician in a Phase I interferon study. Cancer Nursing, 379–386.
MayerD.HetrickK.RiggsC. & SherwinS. (1984). Weight loss in patients receiving recombinant leukocyte A interferon (INFLRA): A brief report. Cancer Nursing, 53–56.
MitchellP.H. (1981). Science, research, and the helping process in nursing: An overview, in MitchellP.H. & LoustauA. (Eds.): Concepts basic to nursing (3rd Ed.). New York: McGraw-Hill Book Company.
12.
MoldawerN.P. & MurrayJ.L. (1985). The clinical uses of monoclonal antibodies in cancer research. Cancer Nursing, 8(4), 207–213.
13.
ScognaD.M. & SchoenbergerC.S. (1982). Biological response modifiers: An overview and nursing implications. Oncology Nursing Forum, 9(1), 45–49.